Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostaglandins and hypercalcemic states.

H W Seyberth, L G Raisz, J A Oates

    Annual Review of Medicine
    |January 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Prostaglandins of the E series may cause hypercalcemia in cancer. Further research into prostaglandin metabolism and targeted therapies could offer new treatment options for this condition.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    DETERMINATION OF BRADYKININ AND KALLIKREIN AS DIAGNOSTIC METHODS IN CARDIOVASCULAR DISEASE.

    A listing of research in the cardiovascular field·2014
    Same author

    (R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2.

    Nature chemical biology·2011
    Same author

    Neurological picture. Fast-growing adenoid cystic carcinoma: a neurotropic malignancy.

    Journal of neurology, neurosurgery, and psychiatry·2006
    Same author

    Effective NSAID treatment indicates that hyperprostaglandinism is affecting the clinical severity of childhood hypophosphatasia.

    Orphanet journal of rare diseases·2006
    Same author

    Renal cortical regulation of COX-1 and functionally related products in early renovascular hypertension (rat).

    American journal of physiology. Renal physiology·2006
    Same author

    An aspirin responsive non-progressive chronic chorea.

    Journal of neurology, neurosurgery, and psychiatry·2006

    Area of Science:

    • Biochemistry
    • Oncology
    • Pharmacology

    Background:

    • Prostaglandins of the E series are implicated in mediating hypercalcemia associated with neoplastic diseases.
    • The precise contribution of various prostaglandin endoperoxide metabolites and their production sites to hypercalcemia remains unclear.

    Purpose of the Study:

    • To elucidate the specific mechanisms of hypercalcemia in neoplastic disease by analyzing prostaglandin endoperoxide metabolism.
    • To explore the potential of prostaglandin cyclo-oxygenase inhibitors and end-organ antagonists in managing hypercalcemia.

    Main Methods:

    • Quantitative analysis of prostaglandin metabolites in tumor tissue, bone tissue, and circulation.
    • Evaluation of therapeutic strategies involving prostaglandin synthesis inhibitors.

    Related Experiment Videos

    Main Results:

    • Quantitative analysis enables the identification of prostaglandin-dependent hypercalcemia.
    • Inhibitors of prostaglandin cyclo-oxygenase show feasibility for treating prostaglandin-mediated hypercalcemia, though broad utility requires further assessment.

    Conclusions:

    • Further investigation into prostaglandin metabolism is crucial for understanding cancer-related hypercalcemia.
    • Therapeutic strategies targeting prostaglandin pathways, including inhibitors and antagonists, hold promise for managing hypercalcemia in cancer patients.